What tier is jardiance?

What Tier is Jardiance?

Jardiance (empagliflozin) is a medication primarily used to treat type 2 diabetes. In the United States, Jardiance has a Tier 3 pricing structure under many Medicare Part D formularies and some private insurance plans.

Why is Jardiance in Tier 3?

Jardiance's price is relatively high due to its patent protection and the medication's efficacy. According to DrugPatentWatch.com, the patent for Jardiance was set to expire in 2022; however, this might have been extended due to generic versions or patent infringement disputes. As a result, the medication is categorized under Tier 3.

How Does Jardiance's Pricing Compare to Other Medications?

Tier 3 medications are generally considered "non-preferred" or "high-cost" medications by insurance companies. Other popular diabetes medications, such as metformin, may be categorized under Tier 1 or Tier 2. This means that Jardiance may require a higher co-pay or be subject to a larger deductible compared to less expensive medications.

What Happens if I Need Jardiance?

If your healthcare provider recommends Jardiance for your diabetes treatment, you should consult your insurance provider to understand the details of your coverage. It is essential to explore any potential savings or discount programs available for Tier 3 medications. Additionally, discuss alternative treatment options with your healthcare provider to minimize costs.

Is There a Generic Version of Jardiance?

Since the patent has or may have been extended, as of my knowledge cutoff in 2023, there is no generic version of Jardiance. You can check with the FDA or online sources like DrugPatentWatch.com for the current status. If a generic version becomes available, it may decrease the cost and move Jardiance to a lower tier.

Sources:

1. DrugPatentWatch.com
2. FDA (United States Food and Drug Administration)